OrthoLogic
This article was originally published in The Gray Sheet
Executive Summary
Firm no longer co-markets Hyalgan osteoarthritis treatment, as was reported in "The Gray Sheet" (July 9, 2001, p. 9); the arrangement expired at the end of 2000 (1"The Gray Sheet" Feb. 5, 2001, p. 4)